Astria Therapeutics Inc | S-8:员工福利计划证券登记
Astria Therapeutics Inc | 10-Q:2024财年二季报
Astria Therapeutics Inc | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(12.193%),Abigail P. Johnson(12.193%)
Astria Therapeutics Inc | 4:持股变动声明-董事 LAPOINTE ANTHONY GREGG
Astria Therapeutics Inc | 4:持股变动声明-董事 Beck Joanne T.
Astria Therapeutics Inc | 4:持股变动声明-董事 Violin Jonathan
Astria Therapeutics Inc | 4:持股变动声明-董事 Callori Fred
Astria Therapeutics Inc | 4:持股变动声明-董事 Cole Hugh M
Astria Therapeutics Inc | 4:持股变动声明-董事 KISHBAUCH MICHAEL D
Astria Therapeutics Inc | 8-K:重大事件
Astria Therapeutics Inc | 4:持股变动声明-董事 BATE KENNETH
Astria Therapeutics Inc | 10-Q:2024财年一季报
Astria Therapeutics Inc | DEFA14A:其他
Astria Therapeutics Inc | ARS:年度报告
Astria Therapeutics Inc | DEF 14A:股东委托书决议
Astria Therapeutics Inc | 4:持股变动声明-董事 AGARWAL SUNIL
Astria Therapeutics Inc | 3:首次持股声明-董事 AGARWAL SUNIL
Astria Therapeutics Inc | 8-K:重大事件
Astria Therapeutics Inc | 4:持股变动声明-高管 Morabito Christopher
Astria Therapeutics Inc | 144:拟议出售证券
暂无数据
暂无数据